FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

System Upgrade Notice
June 22, 2016

MQA Online Services will be unavailable from 6PM on Saturday, June 25th to 8PM on Tuesday, June 28th 2016 for system upgrades. Continue reading


Board Mourns Tragedy in Orlando, Gives Thanks to Health Care Responders
June 17, 2016

As we mourn the tragic events that occurred in Orlando over the weekend, the Division of Medical Quality Assurance joins friends and colleagues in Central Florida and across the state to thank the dedicated health care professionals who have so … Continue reading